Home > Insider Trading > Filing (0001209191-10-023464)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224091	L David Mahoney	C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-21	48,952	$1.66	1,118,062	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Disposition	2010-04-21	48,952	$0.13	48,952	$1.66
Common Stock	Warrants	Acquisiton	2010-04-21	48,952	$0.13	48,952	$2.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-10-16	2012-10-16	No	4	X	Indirect
48,952	2010-04-21	2013-04-21	No	4	P	Indirect

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$5.00		2014-07-20	60,000	60,000	Direct
Common Stock	Stock Option (right to buy)	$4.95		2016-03-02	10,000	10,000	Direct
Common Stock	Stock option (right to buy)	$2.70		2017-12-19	30,000	30,000	Direct
Common Stock	Warrants	$2.77	2008-03-25	2015-03-24	30,534	65,838	Indirect
Common Stock	Stock Option (right to buy)	$2.23		2018-06-10	30,000	30,000	Direct
Common Stock	Stock Option (right to buy)	$0.96		2019-06-11	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-07-20	60,000	60,000	Direct
2016-03-02	10,000	10,000	Direct
2017-12-19	30,000	30,000	Direct
2015-03-24	30,534	65,838	Indirect
2018-06-10	30,000	30,000	Direct
2019-06-11	50,000	50,000	Direct

Footnotes

Issuance of common stock upon exercise of warrant in accordance with the Securities Purchase Agreement dated as of October 12, 2009.
Immediately exercisable subject to a right of repurchase by Corcept Therapeutics Incorporated that shall lapse at the rate of 20% of the total option shares on 7/20/2005 and an additional 1.67% of the total option shares on each monthly anniverary of 7/20/2005.
Exercisable with respect to 25% of the total number of Option Shares one year after 3/2/2006 and with respect to an additional 2.0834% of the total number of Option Shares on the monthly anniversary of 3/2/2006 each month thereafter.
Exercisable with respect to 8.3334% of the total optionsshares on each monthly anniversary of June 11, 2007 so that the entirety of the option grant will vest in one year.
Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 10, 2008 so that the entirety of the option grant will vest within one year.
Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 11, 2009 so that the entirety of the option grant will vest on or before the date of Corcept's next Annual Meeting of Stockholders.
Acquired from the issuer pursuant to a Warrant Purchase Agreement dated April 21, 2010 whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued in October 2009 (see also Footnote #1 above).